117 related articles for article (PubMed ID: 18239068)
1. The nutritional flavanone naringenin triggers antiestrogenic effects by regulating estrogen receptor alpha-palmitoylation.
Galluzzo P; Ascenzi P; Bulzomi P; Marino M
Endocrinology; 2008 May; 149(5):2567-75. PubMed ID: 18239068
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of naringenin-induced apoptotic cascade in cancer cells: involvement of estrogen receptor alpha and beta signalling.
Totta P; Acconcia F; Leone S; Cardillo I; Marino M
IUBMB Life; 2004 Aug; 56(8):491-9. PubMed ID: 15545229
[TBL] [Abstract][Full Text] [Related]
3. Naringenin and 17beta-estradiol coadministration prevents hormone-induced human cancer cell growth.
Bulzomi P; Bolli A; Galluzzo P; Leone S; Acconcia F; Marino M
IUBMB Life; 2010 Jan; 62(1):51-60. PubMed ID: 19960539
[TBL] [Abstract][Full Text] [Related]
4. A naringenin-tamoxifen combination impairs cell proliferation and survival of MCF-7 breast cancer cells.
Hatkevich T; Ramos J; Santos-Sanchez I; Patel YM
Exp Cell Res; 2014 Oct; 327(2):331-9. PubMed ID: 24881818
[TBL] [Abstract][Full Text] [Related]
5. Nutritional flavonoids modulate estrogen receptor alpha signaling.
Virgili F; Acconcia F; Ambra R; Rinna A; Totta P; Marino M
IUBMB Life; 2004 Mar; 56(3):145-51. PubMed ID: 15185748
[TBL] [Abstract][Full Text] [Related]
6. The naringenin-induced proapoptotic effect in breast cancer cell lines holds out against a high bisphenol a background.
Bulzomi P; Bolli A; Galluzzo P; Acconcia F; Ascenzi P; Marino M
IUBMB Life; 2012 Aug; 64(8):690-6. PubMed ID: 22692793
[TBL] [Abstract][Full Text] [Related]
7. Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptor α and β.
Rossi V; Bellastella G; De Rosa C; Abbondanza C; Visconti D; Maione L; Chieffi P; Della Ragione F; Prezioso D; De Bellis A; Bellastella A; Sinisi AA
J Cell Physiol; 2011 May; 226(5):1334-9. PubMed ID: 20945400
[TBL] [Abstract][Full Text] [Related]
8. Palmitoylation regulates 17β-estradiol-induced estrogen receptor-α degradation and transcriptional activity.
La Rosa P; Pesiri V; Leclercq G; Marino M; Acconcia F
Mol Endocrinol; 2012 May; 26(5):762-74. PubMed ID: 22446104
[TBL] [Abstract][Full Text] [Related]
9. Role of ERbeta palmitoylation in the inhibition of human colon cancer cell proliferation.
Galluzzo P; Caiazza F; Moreno S; Marino M
Endocr Relat Cancer; 2007 Mar; 14(1):153-67. PubMed ID: 17395984
[TBL] [Abstract][Full Text] [Related]
10. TAS-108, a novel oral steroidal antiestrogenic agent, is a pure antagonist on estrogen receptor alpha and a partial agonist on estrogen receptor beta with low uterotrophic effect.
Yamamoto Y; Shibata J; Yonekura K; Sato K; Hashimoto A; Aoyagi Y; Wierzba K; Yano S; Asao T; Buzdar AU; Terada T
Clin Cancer Res; 2005 Jan; 11(1):315-22. PubMed ID: 15671561
[TBL] [Abstract][Full Text] [Related]
11. Palmitoylation-dependent estrogen receptor alpha membrane localization: regulation by 17beta-estradiol.
Acconcia F; Ascenzi P; Bocedi A; Spisni E; Tomasi V; Trentalance A; Visca P; Marino M
Mol Biol Cell; 2005 Jan; 16(1):231-7. PubMed ID: 15496458
[TBL] [Abstract][Full Text] [Related]
12. Survival versus apoptotic 17beta-estradiol effect: role of ER alpha and ER beta activated non-genomic signaling.
Acconcia F; Totta P; Ogawa S; Cardillo I; Inoue S; Leone S; Trentalance A; Muramatsu M; Marino M
J Cell Physiol; 2005 Apr; 203(1):193-201. PubMed ID: 15389627
[TBL] [Abstract][Full Text] [Related]
13. Membrane association of estrogen receptor alpha and beta influences 17beta-estradiol-mediated cancer cell proliferation.
Marino M; Ascenzi P
Steroids; 2008 Oct; 73(9-10):853-8. PubMed ID: 18206197
[TBL] [Abstract][Full Text] [Related]
14. Double directional adjusting estrogenic effect of naringin from Rhizoma drynariae (Gusuibu).
Guo D; Wang J; Wang X; Luo H; Zhang H; Cao D; Chen L; Huang N
J Ethnopharmacol; 2011 Nov; 138(2):451-7. PubMed ID: 21964193
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol exhibits cytostatic and antiestrogenic properties with human endometrial adenocarcinoma (Ishikawa) cells.
Bhat KP; Pezzuto JM
Cancer Res; 2001 Aug; 61(16):6137-44. PubMed ID: 11507064
[TBL] [Abstract][Full Text] [Related]
16. Xenoestrogens alter estrogen receptor (ER) α intracellular levels.
La Rosa P; Pellegrini M; Totta P; Acconcia F; Marino M
PLoS One; 2014; 9(2):e88961. PubMed ID: 24586459
[TBL] [Abstract][Full Text] [Related]
17. Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells.
Marsaud V; Gougelet A; Maillard S; Renoir JM
Mol Endocrinol; 2003 Oct; 17(10):2013-27. PubMed ID: 12855746
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor alpha (ERalpha) and insulin-like growth factor I receptor (IGF-IR) cross-talk in the gonadotropic alphaT3-1 cell line.
Eertmans F; Dhooge W; De Wever O; Bracke M; Comhaire F; Kaufman JM
J Cell Physiol; 2007 Sep; 212(3):583-90. PubMed ID: 17458895
[TBL] [Abstract][Full Text] [Related]
19. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
[TBL] [Abstract][Full Text] [Related]
20. S-palmitoylation modulates human estrogen receptor-alpha functions.
Acconcia F; Ascenzi P; Fabozzi G; Visca P; Marino M
Biochem Biophys Res Commun; 2004 Apr; 316(3):878-83. PubMed ID: 15033483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
